C07C 311/04
To acyclic carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
Official title: to acyclic carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
C07C311/04 (To acyclic carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms) appears on 128 US grants and 122 published applications in this corpus.
Search patents in C07C- Granted patents
- 128
- Published applications
- 122
- Assignees
- 80
- Inventors
- 408
- Latest grant
- 9 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 2 | 0 |
| 1991 | 2 | 0 |
| 1992 | 5 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 3 | 0 |
| 1996 | 3 | 0 |
| 1997 | 4 | 0 |
| 1998 | 3 | 0 |
| 1999 | 6 | 0 |
| 2000 | 5 | 0 |
| 2001 | 10 | 1 |
| 2002 | 10 | 6 |
| 2003 | 8 | 11 |
| 2004 | 7 | 8 |
| 2005 | 2 | 10 |
| 2006 | 6 | 5 |
| 2007 | 3 | 5 |
| 2008 | 0 | 5 |
| 2009 | 5 | 7 |
| 2010 | 6 | 10 |
| 2011 | 8 | 4 |
| 2012 | 3 | 7 |
| 2013 | 4 | 5 |
| 2014 | 5 | 4 |
| 2015 | 3 | 4 |
| 2016 | 1 | 3 |
| 2017 | 4 | 6 |
| 2018 | 1 | 3 |
| 2019 | 1 | 2 |
| 2020 | 0 | 4 |
| 2021 | 1 | 2 |
| 2022 | 3 | 2 |
| 2023 | 0 | 2 |
| 2024 | 1 | 4 |
| 2025 | 1 | 2 |
By publication year. Applications have been published since 2001.
Recent patents
- Compound useful as toll-like receptor 7 activation inhibitor9 Sep 2025US 12,410,157 B2National Institute of Advanced Industrial Science and Technology
- Bisphenol derivatives and their use as androgen receptor activity modulators5 Mar 2024US 11,919,874 B2Provincial Health Services Authority
- Methods for making functionalized fluorinated monomers, fluorinated monomers, and compositions for making the same8 Nov 2022US 11,492,318 B2Etna-TEC, Ltd.
- Androgen receptor modulators and methods for their use1 Nov 2022US 11,485,713 B2ESSA Pharma, Inc.
- Heterocyclic inhibitors of the sodium channel1 Feb 2022US 11,236,078 B2
- Bisphenol derivatives and their use as androgen receptor activity modulators27 Mar 2025US 2025/0100986 A1Provincial Health Services Authority
- Analogs of 4-bromo-2,5-dimethoxyphenethylamine13 Feb 2025US 2025/0049748 A1
- Salt compound and quencher, photoresist composition comprising the same10 Oct 2024US 2024/0337930 A1Dongjin Semichem Co., Ltd.
- Perfluorinated amide salts and their uses as ionic conducting materials1 Aug 2024US 2024/0253023 A1
- Methods of treating chronic obstructive pulmonary disease including compounds useful therein1 Aug 2024US 2024/0254077 A1The Trustees of Columbia University in the City of New York
Most cited
By later US patents
- Benzene compound having 2 or more substituents87US 7,923,573 B2Daiichi Sankyo Company, Limited · 2011
- Methods of treating cardiovascular diseases, dyslipidemia, dyslipoproteinemia, and hypertension with ether compounds81US 6,506,799 B1Esperion Therapeutics, Inc. · 2003
- Heteroatom containing perfluoroalkyl terminated neopentyl glycols and compositions therefrom61US 4,946,992 ACiba-Geigy Corporation · 1990
- Perfluorinated amide salts and their uses as ionic conducting materials61US 6,319,428 B1Centre National De La Recherche Scientifique · 2001
- Heteroatom containing perfluoroalkyl terminated neopentyl glycols and compositions therefrom58US 4,898,981 ACiba-Geigy Corporation · 1990